Proportion of isolates with resistance to ciprofloxacin reported to WHO-GASP
Filters
Proportion of isolates with resistance to ciprofloxacin reported to WHO-GASP
Bahrain
Proportion of isolates with resistance to ciprofloxacin reported to WHO-GASP
20172017
Reported ciprofloxacin resistance in gonorrhea by country in 2018 (proportion of isolates with resistance to ciprofloxacin reported to WHO-GASP)
In 2018, Ecuador had the highest value (100) among 65 countries.
| # | Country | Value | Change |
|---|---|---|---|
| 1 | Ecuador | 100 | +25.0% |
| 1 | El Salvador (2017) | 100 | 0.0% |
| 1 | Myanmar (2016) | 100 | 0.0% |
| 1 | Madagascar | 100 | +7.3% |
| 1 | Cambodia | 100 | +8.3% |
| 1 | Indonesia (2016) | 100 | 0.0% |
Similar Datasets
Proportion of isolates with decreased susceptibility or resistance (DS/R) to ceftriaxone reported to WHO-GASP
WHO (GASPRSCRO)
Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP
WHO (GASPRSCFM)
Proportion of isolates with resistance to azithromycin reported to WHO-GASP
WHO (GASPRSAZM)
Proportion of isolates with decreased susceptibility or resistance (DS/R) to extended-spectrum cephalosporins reported to WHO-GASP
WHO (GASPRSESC)